English
简体中文
Total: £ 56.28
Published Date: 2026-02-06 | Pages: 137 | Tables: 130 | Medical Care
The global Mesenchymal Stem Cells market was valued at US$ 1389 million in 2025 and is anticipated to reach US$ 2785 million by 2032, at a CAGR of 10.6% from 2026 to 2032.
Mesenchymal Stem Cells (MSCs) are multipotent stem cells derived from various tissues such as bone marrow, umbilical cord, adipose tissue, and placenta. They possess strong self-renewal and multilineage differentiation capabilities, enabling them to differentiate into osteoblasts, chondrocytes, adipocytes, and other mesenchymal-origin cells. MSCs are characterized by low immunogenicity, immunomodulatory effects, and robust cytokine secretion, making them a key focus in regenerative medicine, immune therapy, and anti-inflammatory treatment. With advancements in cell culture techniques, serum-free media, and GMP-compliant manufacturing, MSCs are transitioning from preclinical research to clinical applications, finding broad use in orthopedic disorders, cardiovascular diseases, autoimmune conditions, oncology, and tissue engineering. The MSC industry spans upstream cell sourcing, large-scale expansion, cryopreservation, logistics, and therapeutic product development, positioning MSCs as a cornerstone of the global cell and gene therapy (CGT) market and a critical driver of precision medicine, drawing strong attention from investors and regulatory authorities worldwide.
The mesenchymal stem cell (MSC) industry is entering a phase of accelerated growth, driven by the global boom in cell and gene therapy R&D, rising healthcare needs of aging populations, and supportive regenerative medicine policies. According to public annual reports, the number of ongoing MSC clinical trials continues to grow, with over 300 trials registered in the U.S. and China in 2024 alone, covering neurological, metabolic, and autoimmune disorders. Governments are investing heavily in innovation, supporting GMP-compliant manufacturing facilities and quality standardization, reducing technical barriers. Frequent collaborations between multinational pharmaceutical companies and regional CDMOs are facilitating industrial-scale production and rapid market penetration. With increasing investments from Asia and the Middle East, MSCs are poised to become a strategic focus in global precision and personalized medicine development.
Despite rapid growth, the MSC industry faces challenges such as complex cell sourcing, difficulties in large-scale manufacturing, inconsistent clinical protocols, and varying regulatory requirements across regions. Many companies lack mature experience in process optimization and batch consistency, resulting in high costs and extended commercialization timelines. Intellectual property barriers, cross-border clinical certifications, and global regulatory complexities further increase entry thresholds, particularly for small and mid-sized players. Market uncertainties, including fluctuations in capital markets and healthcare reimbursement policies, also pose risks. Balancing strict quality standards, cost efficiency, and accessible pricing will be critical for shaping the competitive landscape.
Demand is rapidly shifting from basic research to commercial clinical applications. The growth of immunotherapy, tissue engineering, and personalized medicine is expanding MSC use cases, including cardiovascular repair, cartilage regeneration, autoimmune disease management, anti-aging therapies, and medical aesthetics. Emerging integration with mRNA technology and gene editing is creating vast opportunities for premium, customized MSC products. Companies and research institutions are accelerating automation and digital process control to enhance product consistency and reduce costs. The convergence of aging demographics, chronic disease prevalence, and supportive policy frameworks positions MSCs as a central growth engine in the global cell therapy market over the next five years.
This report delivers a comprehensive overview of the global Mesenchymal Stem Cells market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mesenchymal Stem Cells. The Mesenchymal Stem Cells market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mesenchymal Stem Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CellResearch
StemCord
Cytopeutics
CryoCord
Cell Malaysia
Bangkok Stem Cell
Vinmec Stem Cell Institute
ProSTEM
Cryoviva
StemCells21
Lonza
Thermo Fisher Scientific
PromoCell
Stemcell Technologies
Bio-Techne
ATCC
Merck
Segment by Type
Umbilical Cord Derived MSC
Bone Marrow Derived MSC
Placenta Derived MSC
Other
Segment by Application
Research
Disease Treatment
Beauty and Anti-aging
Storage
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Mesenchymal Stem Cells companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Umbilical Cord Derived MSC
1.2.3 Bone Marrow Derived MSC
1.2.4 Placenta Derived MSC
1.2.5 Other
1.3 Market by Application
1.3.1 Global Mesenchymal Stem Cells Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Research
1.3.3 Disease Treatment
1.3.4 Beauty and Anti-aging
1.3.5 Storage
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mesenchymal Stem Cells Market Perspective (2021–2032)
2.2 Global Mesenchymal Stem Cells Growth Trends by Region
2.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Mesenchymal Stem Cells Historic Market Size by Region (2021–2026)
2.2.3 Mesenchymal Stem Cells Forecasted Market Size by Region (2027–2032)
2.3 Mesenchymal Stem Cells Market Dynamics
2.3.1 Mesenchymal Stem Cells Industry Trends
2.3.2 Mesenchymal Stem Cells Market Drivers
2.3.3 Mesenchymal Stem Cells Market Challenges
2.3.4 Mesenchymal Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mesenchymal Stem Cells Players by Revenue
3.1.1 Global Top Mesenchymal Stem Cells Players by Revenue (2021–2026)
3.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2021–2026)
3.2 Global Top Mesenchymal Stem Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Mesenchymal Stem Cells Revenue
3.4 Global Mesenchymal Stem Cells Market Concentration Ratio
3.4.1 Global Mesenchymal Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cells Revenue in 2025
3.5 Global Key Players of Mesenchymal Stem Cells Head Offices and Areas Served
3.6 Global Key Players of Mesenchymal Stem Cells, Products and Applications
3.7 Global Key Players of Mesenchymal Stem Cells, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Mesenchymal Stem Cells Breakdown Data by Type
4.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2021–2026)
4.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2027–2032)
5 Mesenchymal Stem Cells Breakdown Data by Application
5.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2021–2026)
5.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Mesenchymal Stem Cells Market Size (2021–2032)
6.2 North America Mesenchymal Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Mesenchymal Stem Cells Market Size by Country (2021–2026)
6.4 North America Mesenchymal Stem Cells Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mesenchymal Stem Cells Market Size (2021–2032)
7.2 Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Mesenchymal Stem Cells Market Size by Country (2021–2026)
7.4 Europe Mesenchymal Stem Cells Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Mesenchymal Stem Cells Market Size (2021–2032)
8.2 Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2021–2026)
8.4 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Mesenchymal Stem Cells Market Size (2021–2032)
9.2 Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Mesenchymal Stem Cells Market Size by Country (2021–2026)
9.4 Latin America Mesenchymal Stem Cells Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mesenchymal Stem Cells Market Size (2021–2032)
10.2 Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021–2026)
10.4 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CellResearch
11.1.1 CellResearch Company Details
11.1.2 CellResearch Business Overview
11.1.3 CellResearch Mesenchymal Stem Cells Introduction
11.1.4 CellResearch Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.1.5 CellResearch Recent Development
11.2 StemCord
11.2.1 StemCord Company Details
11.2.2 StemCord Business Overview
11.2.3 StemCord Mesenchymal Stem Cells Introduction
11.2.4 StemCord Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.2.5 StemCord Recent Development
11.3 Cytopeutics
11.3.1 Cytopeutics Company Details
11.3.2 Cytopeutics Business Overview
11.3.3 Cytopeutics Mesenchymal Stem Cells Introduction
11.3.4 Cytopeutics Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.3.5 Cytopeutics Recent Development
11.4 CryoCord
11.4.1 CryoCord Company Details
11.4.2 CryoCord Business Overview
11.4.3 CryoCord Mesenchymal Stem Cells Introduction
11.4.4 CryoCord Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.4.5 CryoCord Recent Development
11.5 Cell Malaysia
11.5.1 Cell Malaysia Company Details
11.5.2 Cell Malaysia Business Overview
11.5.3 Cell Malaysia Mesenchymal Stem Cells Introduction
11.5.4 Cell Malaysia Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.5.5 Cell Malaysia Recent Development
11.6 Bangkok Stem Cell
11.6.1 Bangkok Stem Cell Company Details
11.6.2 Bangkok Stem Cell Business Overview
11.6.3 Bangkok Stem Cell Mesenchymal Stem Cells Introduction
11.6.4 Bangkok Stem Cell Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.6.5 Bangkok Stem Cell Recent Development
11.7 Vinmec Stem Cell Institute
11.7.1 Vinmec Stem Cell Institute Company Details
11.7.2 Vinmec Stem Cell Institute Business Overview
11.7.3 Vinmec Stem Cell Institute Mesenchymal Stem Cells Introduction
11.7.4 Vinmec Stem Cell Institute Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.7.5 Vinmec Stem Cell Institute Recent Development
11.8 ProSTEM
11.8.1 ProSTEM Company Details
11.8.2 ProSTEM Business Overview
11.8.3 ProSTEM Mesenchymal Stem Cells Introduction
11.8.4 ProSTEM Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.8.5 ProSTEM Recent Development
11.9 Cryoviva
11.9.1 Cryoviva Company Details
11.9.2 Cryoviva Business Overview
11.9.3 Cryoviva Mesenchymal Stem Cells Introduction
11.9.4 Cryoviva Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.9.5 Cryoviva Recent Development
11.10 StemCells21
11.10.1 StemCells21 Company Details
11.10.2 StemCells21 Business Overview
11.10.3 StemCells21 Mesenchymal Stem Cells Introduction
11.10.4 StemCells21 Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.10.5 StemCells21 Recent Development
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Mesenchymal Stem Cells Introduction
11.11.4 Lonza Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.11.5 Lonza Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Mesenchymal Stem Cells Introduction
11.12.4 Thermo Fisher Scientific Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 PromoCell
11.13.1 PromoCell Company Details
11.13.2 PromoCell Business Overview
11.13.3 PromoCell Mesenchymal Stem Cells Introduction
11.13.4 PromoCell Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.13.5 PromoCell Recent Development
11.14 Stemcell Technologies
11.14.1 Stemcell Technologies Company Details
11.14.2 Stemcell Technologies Business Overview
11.14.3 Stemcell Technologies Mesenchymal Stem Cells Introduction
11.14.4 Stemcell Technologies Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.14.5 Stemcell Technologies Recent Development
11.15 Bio-Techne
11.15.1 Bio-Techne Company Details
11.15.2 Bio-Techne Business Overview
11.15.3 Bio-Techne Mesenchymal Stem Cells Introduction
11.15.4 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.15.5 Bio-Techne Recent Development
11.16 ATCC
11.16.1 ATCC Company Details
11.16.2 ATCC Business Overview
11.16.3 ATCC Mesenchymal Stem Cells Introduction
11.16.4 ATCC Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.16.5 ATCC Recent Development
11.17 Merck
11.17.1 Merck Company Details
11.17.2 Merck Business Overview
11.17.3 Merck Mesenchymal Stem Cells Introduction
11.17.4 Merck Revenue in Mesenchymal Stem Cells Business (2021–2026)
11.17.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mesenchymal Stem Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Umbilical Cord Derived MSC
Table 3. Key Players of Bone Marrow Derived MSC
Table 4. Key Players of Placenta Derived MSC
Table 5. Key Players of Other
Table 6. Global Mesenchymal Stem Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Mesenchymal Stem Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Mesenchymal Stem Cells Market Size by Region (US$ Million), 2021–2026
Table 9. Global Mesenchymal Stem Cells Market Share by Region (2021–2026)
Table 10. Global Mesenchymal Stem Cells Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Mesenchymal Stem Cells Market Share by Region (2027–2032)
Table 12. Mesenchymal Stem Cells Market Trends
Table 13. Mesenchymal Stem Cells Market Drivers
Table 14. Mesenchymal Stem Cells Market Challenges
Table 15. Mesenchymal Stem Cells Market Restraints
Table 16. Global Mesenchymal Stem Cells Revenue by Players (US$ Million), 2021–2026
Table 17. Global Mesenchymal Stem Cells Market Share by Players (2021–2026)
Table 18. Global Top Mesenchymal Stem Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Mesenchymal Stem Cells Revenue, 2025
Table 19. Ranking of Global Top Mesenchymal Stem Cells Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Mesenchymal Stem Cells Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Mesenchymal Stem Cells, Headquarters and Area Served
Table 22. Global Key Players of Mesenchymal Stem Cells, Products and Applications
Table 23. Global Key Players of Mesenchymal Stem Cells, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Mesenchymal Stem Cells Market Size by Type (US$ Million), 2021–2026
Table 26. Global Mesenchymal Stem Cells Revenue Market Share by Type (2021–2026)
Table 27. Global Mesenchymal Stem Cells Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Mesenchymal Stem Cells Revenue Market Share by Type (2027–2032)
Table 29. Global Mesenchymal Stem Cells Market Size by Application (US$ Million), 2021–2026
Table 30. Global Mesenchymal Stem Cells Revenue Market Share by Application (2021–2026)
Table 31. Global Mesenchymal Stem Cells Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Mesenchymal Stem Cells Revenue Market Share by Application (2027–2032)
Table 33. North America Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Mesenchymal Stem Cells Market Size by Country (US$ Million), 2021–2026
Table 35. North America Mesenchymal Stem Cells Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Mesenchymal Stem Cells Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Mesenchymal Stem Cells Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Mesenchymal Stem Cells Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Mesenchymal Stem Cells Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Mesenchymal Stem Cells Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Mesenchymal Stem Cells Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (US$ Million), 2027–2032
Table 48. CellResearch Company Details
Table 49. CellResearch Business Overview
Table 50. CellResearch Mesenchymal Stem Cells Product
Table 51. CellResearch Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 52. CellResearch Recent Development
Table 53. StemCord Company Details
Table 54. StemCord Business Overview
Table 55. StemCord Mesenchymal Stem Cells Product
Table 56. StemCord Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 57. StemCord Recent Development
Table 58. Cytopeutics Company Details
Table 59. Cytopeutics Business Overview
Table 60. Cytopeutics Mesenchymal Stem Cells Product
Table 61. Cytopeutics Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 62. Cytopeutics Recent Development
Table 63. CryoCord Company Details
Table 64. CryoCord Business Overview
Table 65. CryoCord Mesenchymal Stem Cells Product
Table 66. CryoCord Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 67. CryoCord Recent Development
Table 68. Cell Malaysia Company Details
Table 69. Cell Malaysia Business Overview
Table 70. Cell Malaysia Mesenchymal Stem Cells Product
Table 71. Cell Malaysia Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 72. Cell Malaysia Recent Development
Table 73. Bangkok Stem Cell Company Details
Table 74. Bangkok Stem Cell Business Overview
Table 75. Bangkok Stem Cell Mesenchymal Stem Cells Product
Table 76. Bangkok Stem Cell Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 77. Bangkok Stem Cell Recent Development
Table 78. Vinmec Stem Cell Institute Company Details
Table 79. Vinmec Stem Cell Institute Business Overview
Table 80. Vinmec Stem Cell Institute Mesenchymal Stem Cells Product
Table 81. Vinmec Stem Cell Institute Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 82. Vinmec Stem Cell Institute Recent Development
Table 83. ProSTEM Company Details
Table 84. ProSTEM Business Overview
Table 85. ProSTEM Mesenchymal Stem Cells Product
Table 86. ProSTEM Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 87. ProSTEM Recent Development
Table 88. Cryoviva Company Details
Table 89. Cryoviva Business Overview
Table 90. Cryoviva Mesenchymal Stem Cells Product
Table 91. Cryoviva Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 92. Cryoviva Recent Development
Table 93. StemCells21 Company Details
Table 94. StemCells21 Business Overview
Table 95. StemCells21 Mesenchymal Stem Cells Product
Table 96. StemCells21 Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 97. StemCells21 Recent Development
Table 98. Lonza Company Details
Table 99. Lonza Business Overview
Table 100. Lonza Mesenchymal Stem Cells Product
Table 101. Lonza Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 102. Lonza Recent Development
Table 103. Thermo Fisher Scientific Company Details
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Mesenchymal Stem Cells Product
Table 106. Thermo Fisher Scientific Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 107. Thermo Fisher Scientific Recent Development
Table 108. PromoCell Company Details
Table 109. PromoCell Business Overview
Table 110. PromoCell Mesenchymal Stem Cells Product
Table 111. PromoCell Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 112. PromoCell Recent Development
Table 113. Stemcell Technologies Company Details
Table 114. Stemcell Technologies Business Overview
Table 115. Stemcell Technologies Mesenchymal Stem Cells Product
Table 116. Stemcell Technologies Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 117. Stemcell Technologies Recent Development
Table 118. Bio-Techne Company Details
Table 119. Bio-Techne Business Overview
Table 120. Bio-Techne Mesenchymal Stem Cells Product
Table 121. Bio-Techne Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 122. Bio-Techne Recent Development
Table 123. ATCC Company Details
Table 124. ATCC Business Overview
Table 125. ATCC Mesenchymal Stem Cells Product
Table 126. ATCC Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 127. ATCC Recent Development
Table 128. Merck Company Details
Table 129. Merck Business Overview
Table 130. Merck Mesenchymal Stem Cells Product
Table 131. Merck Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026
Table 132. Merck Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Mesenchymal Stem Cells Picture
Figure 2. Global Mesenchymal Stem Cells Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Mesenchymal Stem Cells Market Share by Type: 2025 vs 2032
Figure 4. Umbilical Cord Derived MSC Features
Figure 5. Bone Marrow Derived MSC Features
Figure 6. Placenta Derived MSC Features
Figure 7. Other Features
Figure 8. Global Mesenchymal Stem Cells Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Mesenchymal Stem Cells Market Share by Application: 2025 vs 2032
Figure 10. Research Case Studies
Figure 11. Disease Treatment Case Studies
Figure 12. Beauty and Anti-aging Case Studies
Figure 13. Storage Case Studies
Figure 14. Mesenchymal Stem Cells Report Years Considered
Figure 15. Global Mesenchymal Stem Cells Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Mesenchymal Stem Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Mesenchymal Stem Cells Market Share by Region: 2025 vs 2032
Figure 18. Global Mesenchymal Stem Cells Market Share by Players in 2025
Figure 19. Global Mesenchymal Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Mesenchymal Stem Cells Revenue in 2025
Figure 21. North America Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Mesenchymal Stem Cells Market Share by Country (2021–2032)
Figure 23. United States Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Mesenchymal Stem Cells Market Share by Country (2021–2032)
Figure 27. Germany Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Mesenchymal Stem Cells Market Share by Region (2021–2032)
Figure 35. China Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Mesenchymal Stem Cells Market Share by Country (2021–2032)
Figure 43. Mexico Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2021–2032)
Figure 47. Israel Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. CellResearch Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 51. StemCord Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 52. Cytopeutics Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 53. CryoCord Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 54. Cell Malaysia Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 55. Bangkok Stem Cell Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 56. Vinmec Stem Cell Institute Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 57. ProSTEM Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 58. Cryoviva Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 59. StemCells21 Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 60. Lonza Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 62. PromoCell Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 63. Stemcell Technologies Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 64. Bio-Techne Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 65. ATCC Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 66. Merck Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
